Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Graft vs Host Disease × sargramostim × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 5 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1

Interventions

ruxolitinib 4 Cyclophosphamide 4 Mycophenolic Acid 3 fludarabine 2 Tacrolimus 2 Methotrexate 2 Busulfan 2 blinatumomab 1 belumosudil 1 axatilimab 1 Whole-Body Irradiation 1 Vorinostat 1 Thiotepa 1 Sirolimus 1 Panobinostat 1 Low-Level Light Therapy 1 Interferon-gamma 1 Cyclosporine 1 Clofarabine 1 Blood Specimen Collection 1 Biopsy 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡